Use of a polypeptide with an angiotensin converting enzyme-2 (ACE2) activity for the manufacture of a medicament to treat tumor diseases, except lung cancer, is claimed. ACTIVITY : Cytostatic; Antiinflammatory; Vasotropic. MECHANISM OF ACTION : ACE inhibitor; Angiotensin II subtype 1 receptor antagonist.